Arkansas § 23-99-1130 HIV pre-exposure prophylaxis and HIV post-exposure prophylaxis - Definitions

Arkansas Statutes

§ 23-99-1130 — HIV pre-exposure prophylaxis and HIV post-exposure prophylaxis - Definitions

Arkansas § 23-99-1130

Title23

This text of Arkansas § 23-99-1130 (HIV pre-exposure prophylaxis and HIV post-exposure prophylaxis - Definitions) is published on Counsel Stack Legal Research, covering Arkansas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Ark. Code Ann. § 23-99-1130 (2026).

Text

(a)As used in this section:

(1)"AIDS" means acquired immunodeficiency syndrome; and (2) "HIV" means the human immunodeficiency virus or any other identified causative agent of acquired immunodeficiency syndrome.

(b)Except as provided in subsection (c) of this section, a health benefit plan or healthcare insurer shall not require prior authorization or step therapy for antiretroviral drugs that are medically necessary for the prevention of HIV or AIDS, including HIV pre-exposure prophylaxis and HIV post-exposure prophylaxis.

(c)If the United States Food and Drug Administration approves one (1) or more therapeutic equivalents of a drug, device, or product for the prevention of HIV or AIDS, a health benefit plan or healthcare insurer is not required to cover all therapeutically equivalent

Free access — add to your briefcase to read the full text and ask questions with AI

(a) As used in this section: (1) "AIDS" means acquired immunodeficiency syndrome; and (2) "HIV" means the human immunodeficiency virus or any other identified causative agent of acquired immunodeficiency syndrome. (b) Except as provided in subsection (c) of this section, a health benefit plan or healthcare insurer shall not require prior authorization or step therapy for antiretroviral drugs that are medically necessary for the prevention of HIV or AIDS, including HIV pre-exposure prophylaxis and HIV post-exposure prophylaxis. (c) If the United States Food and Drug Administration approves one (1) or more therapeutic equivalents of a drug, device, or product for the prevention of HIV or AIDS, a health benefit plan or healthcare insurer is not required to cover all therapeutically equivalent versions without prior authorization or step therapy if at least one (1) therapeutically equivalent version is covered without prior authorization or step therapy.